Lung transplantation in sarcoidosis: Lessons learned from immunology

Sarcoidosis Vasculitis and Diffuse Lung Disease

Volumn 16, Issue 1, 1999, Pages 21-23

  Semenzato, Gianpietro ^a,b   Agostini, Carlo ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

BRONCHIOLITIS; EDITORIAL; GRAFT REJECTION; HUMAN; IMMUNOLOGY; LUNG LAVAGE; LUNG TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE; SARCOIDOSIS; T LYMPHOCYTE ACTIVATION;

EID: 0032911077     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (16)

1. Semenzato G: Therapy of sarcoidosis. In: Conn's Current Therapy. R.E. Rakel Ed., W.B. Saunders Company, New York; 1999, in press.
2. Newman LS, Rose CS, Maier LA: Sarcoidosis. N Engl J Med 1997; 336: 1224-1234,
3. Padilla ML, Schilero GJ, Teirstein AS: Sarcoidosis and transplantation. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 16-22.
4. Nunley DR, Hattler B, Keenan RJ et al: Lung transplantation for end-stage pulmonary sarcoidosis. Sarcoidosis Vase Diffuse Lung Dis 1999; 16: 93-100.
5. Johnson BA, Duncan SR, Ohori NP et al: Recurrence of sarcoidosis in pulmonary allograft recipients. Am Rev Respir Dis 1993; 148: 1373-1377.
6. Agostini C, Semenzato G, James DG: Immunological, clinical and molecular aspects of sarcoidosis. Mol Aspects Med 1997; 18: 1-98.
7. Semenzato G, Agostini C: Immunologic events in the development of interstitial lung disease: the paradigm of sarcoidosis. In Interstitial Lung Disease, 3rd Edition, MI Schwarz, and TE King Jr, Eds. 1993 BC Dekker Publ., Ontario, Canada, pp 229-250.
8. Lawrence EC, Brousseau KP, Berger MB et al: Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis. Am Rev Respir Dis 1988; 137: 759-764.
9. Lawrence EC, Holland VAP, Young JB et al: Dynamic changes in soluble interleukin-2 receptors after lung or heart-lung transplantation. Am Rev Respir Dis 1989; 140: 789-796.
10. Agostini C, Trentin L, Facco M et al: Role of ILI S, IL-2 and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol 1996; 157: 910-918.
11. Moller DR, Forman JD, Liu MC: Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996; I S6: 4952-4960.
12. Bergeron A, Bonay M, Kambouchner M, Lecossier D, Hance A, Tazi A: Cytokine patterns in tuberculous and sarcoid granulomas. J Immunol 1997; 159: 3034-3043.
13. Semenzato G: Chemotactic cytokines: from molecular level to clinical use. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15: 131-133.
14. Agostini C, Cassatella M, Zambello R et al: Involvement of IP 10 chemokine in sarcoid granulomatous reactions. J Immunol 1998; 161: 6413-6420.
15. Hausen B, Morris RE: Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies. Clin Chest Med 1997; 18: 353-366.
16. Briffa N, Morris RE: New immunosuppressive regimens in lung transplantation. Eur Respir J 1997; 10: 2630-2637.